MARKET TRENDS: Stay Profitable And Protected With This Routine Shares of Ligand Pharmaceuticals (LGND) are absolutely flying, up almost 88% this year, as investors line up behind the company's unique royalty-based business model. Ligand Pharma is a biotech company that doesn't make biologic medicines. Instead, it makes deals. The company has a portfolio of more than 90 partnered commercial and development-stage drugs, including treatments for cancer, kidney disease, diabetes,… Related news Drug Giant Merck ...